OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic and Environmental Factors in P arkinson's Disease Converge on Immune Function and Inflammation
Elizabeth M. Kline, Madelyn C. Houser, Mary K. Herrick, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 25-36
Open Access | Times Cited: 96
Elizabeth M. Kline, Madelyn C. Houser, Mary K. Herrick, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 25-36
Open Access | Times Cited: 96
Showing 26-50 of 96 citing articles:
The role of exosomes in adult neurogenesis: implications for neurodegenerative diseases
Zhuoyang Yu, Yan Teng, Jing Yang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 282-288
Open Access | Times Cited: 16
Zhuoyang Yu, Yan Teng, Jing Yang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 282-288
Open Access | Times Cited: 16
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5618-5618
Open Access | Times Cited: 14
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5618-5618
Open Access | Times Cited: 14
Morphometric similarity differences in drug‐naive Parkinson's disease correlate with transcriptomic signatures
Yajie Wang, Yiwen Xiao, Yi Xing, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 5
Yajie Wang, Yiwen Xiao, Yi Xing, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 5
Richard J. Smeyne, Jeffrey B. Eells, Debotri Chatterjee, et al.
Movement Disorders (2022) Vol. 37, Iss. 7, pp. 1394-1404
Open Access | Times Cited: 19
Quantitative and causal analysis for inflammatory genes and the risk of Parkinson’s disease
Minhan Yi, Jiaxin Li, Shijie Jian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Minhan Yi, Jiaxin Li, Shijie Jian, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Interaction of Mitochondrial Polygenic Score and Lifestyle Factors in LRRK2 p.Gly2019Ser Parkinsonism
Theresa Lüth, Carolin Gabbert, Sebastian Koch, et al.
Movement Disorders (2023) Vol. 38, Iss. 10, pp. 1837-1849
Open Access | Times Cited: 11
Theresa Lüth, Carolin Gabbert, Sebastian Koch, et al.
Movement Disorders (2023) Vol. 38, Iss. 10, pp. 1837-1849
Open Access | Times Cited: 11
Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease
Junming Huang, Bowen Li, Huangwei Wei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Junming Huang, Bowen Li, Huangwei Wei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stress
Janna Jernigan, Hannah A. Staley, Zachary Baty, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Janna Jernigan, Hannah A. Staley, Zachary Baty, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Investigating cuproptosis and mitochondrial dysfunction in brain cells: uncovering novel mechanisms and biomarkers for Parkinson’s disease
Q. Li, Dongliang Li, Yinghong Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Q. Li, Dongliang Li, Yinghong Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study
Wang Hq, Ziji Cheng, Zixuan Xu, et al.
Brain and Behavior (2025) Vol. 15, Iss. 4
Open Access
Wang Hq, Ziji Cheng, Zixuan Xu, et al.
Brain and Behavior (2025) Vol. 15, Iss. 4
Open Access
Neuroprotective approaches to halt Parkinson's disease progression
Piyong Sola, Praveen Thaggikuppe Krishnamurthy, Mamta Kumari, et al.
Neurochemistry International (2022) Vol. 158, pp. 105380-105380
Closed Access | Times Cited: 17
Piyong Sola, Praveen Thaggikuppe Krishnamurthy, Mamta Kumari, et al.
Neurochemistry International (2022) Vol. 158, pp. 105380-105380
Closed Access | Times Cited: 17
The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease
Zhuo Zhang, Yue Wang, Jin Wang, et al.
Parkinsonism & Related Disorders (2024) Vol. 123, pp. 106102-106102
Open Access | Times Cited: 3
Zhuo Zhang, Yue Wang, Jin Wang, et al.
Parkinsonism & Related Disorders (2024) Vol. 123, pp. 106102-106102
Open Access | Times Cited: 3
Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants
Ethan Brown, Samuel M. Goldman, Christopher S. Coffey, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 4, pp. 737-746
Open Access | Times Cited: 3
Ethan Brown, Samuel M. Goldman, Christopher S. Coffey, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 4, pp. 737-746
Open Access | Times Cited: 3
Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
Gabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Journal of Parkinson s Disease (2024), pp. 1-29
Open Access | Times Cited: 3
Gabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Journal of Parkinson s Disease (2024), pp. 1-29
Open Access | Times Cited: 3
Inhibition of T cell infiltration and soluble TNF signaling is neuroprotective in the alpha-synuclein overexpressing mouse model of Parkinson’s disease
Adriana Tavira, Leyre Basurco, Miguel Angel Abellanas, et al.
Research Square (Research Square) (2025)
Closed Access
Adriana Tavira, Leyre Basurco, Miguel Angel Abellanas, et al.
Research Square (Research Square) (2025)
Closed Access
The role of interleukin (IL)-2 cytokine family in Parkinson's disease
Pouya Goleij, Afshin Amini, Mohammad Amin Khazeei Tabari, et al.
Cytokine (2025) Vol. 191, pp. 156954-156954
Closed Access
Pouya Goleij, Afshin Amini, Mohammad Amin Khazeei Tabari, et al.
Cytokine (2025) Vol. 191, pp. 156954-156954
Closed Access
Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson’s disease
Yongang Li, Zongshan Li, Jiachen Gu, et al.
Neuroscience Letters (2021) Vol. 771, pp. 136414-136414
Closed Access | Times Cited: 23
Yongang Li, Zongshan Li, Jiachen Gu, et al.
Neuroscience Letters (2021) Vol. 771, pp. 136414-136414
Closed Access | Times Cited: 23
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Johan Wallin, Per Svenningsson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5606-5606
Open Access | Times Cited: 21
Johan Wallin, Per Svenningsson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5606-5606
Open Access | Times Cited: 21
Gut-Derived Sterile Inflammation and Parkinson's Disease
Kathleen M. Shannon
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
Kathleen M. Shannon
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
Mushroom Natural Products in Neurodegenerative Disease Drug Discovery
Arjuna Abitbol, Brody Mallard, Evelin Tiralongo, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3938-3938
Open Access | Times Cited: 15
Arjuna Abitbol, Brody Mallard, Evelin Tiralongo, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3938-3938
Open Access | Times Cited: 15
Lifestyle factors and clinical severity of Parkinson’s disease
Carolin Gabbert, Inke R. König, Theresa Lüth, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Carolin Gabbert, Inke R. König, Theresa Lüth, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
A functional role for alpha-synuclein in neuroimmune responses
Dustin L. Heiden, Brendan Monogue, Muhammad Ali, et al.
Journal of Neuroimmunology (2023) Vol. 376, pp. 578047-578047
Open Access | Times Cited: 8
Dustin L. Heiden, Brendan Monogue, Muhammad Ali, et al.
Journal of Neuroimmunology (2023) Vol. 376, pp. 578047-578047
Open Access | Times Cited: 8
Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson’s Disease From Mice to Human
Martina Montanari, Paola Imbriani, Paola Bonsi, et al.
(2023)
Open Access | Times Cited: 8
Martina Montanari, Paola Imbriani, Paola Bonsi, et al.
(2023)
Open Access | Times Cited: 8
Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort
Marta Campagnolo, Luca Weis, Michele Sandre, et al.
Neurobiology of Disease (2024) Vol. 200, pp. 106609-106609
Open Access | Times Cited: 3
Marta Campagnolo, Luca Weis, Michele Sandre, et al.
Neurobiology of Disease (2024) Vol. 200, pp. 106609-106609
Open Access | Times Cited: 3
Cholinergic Receptor Modulation as a Target for Preventing Dementia in Parkinson’s Disease
Alexandre Iarkov, Cristhian Mendoza, Valentina Echeverrı́a
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
Alexandre Iarkov, Cristhian Mendoza, Valentina Echeverrı́a
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
